BRCA2 and ovarian cancer: The NCCN and the Society of Gynecologic Oncology both recommend BRCA1 and BRCA2 genetic testing for all women with ovarian cancer, and parallel re-testing of all of these women using multi-gene panels may be warranted due to the observed mutation rates in this group.